Improving Clinical Outcomes for Anemia of Chronic Kidney Disease: A Focus on Novel Treatment Approaches (Pharmacist Credit)

Program Description

Anemia is a common complication of chronic kidney disease (CKD) that is associated with poor clinical outcomes and leads to a substantial burden on patients and health care systems, particularly when left untreated or undertreated. In patients with early-stage CKD, the disease is often underdiagnosed and undertreated. Early detection and effective management of anemia in the setting of CKD is needed to minimize its debilitating effects on patients’ quality of life. Traditional treatment strategies are limited due to adverse complications, highlighting the need for novel therapies. Pharmacists must be well versed in current and emerging strategies to treat and manage anemia of CKD as well as treatments that may be initiated to manage the effects of anemia of CKD. Using evidence-based treatment strategies and individualized patient education, pharmacists will be able to enhance patients’ health-related quality of life and reduce direct and indirect costs of CKD.

Target audience: Health-system pharmacists and retail pharmacists

Type of activity: Application
Release date: April 29, 2022
Expiration date: April 29, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives for Pharmacists

At the completion of this activity, participants will be able to:

• Examine the disease burden associated with anemia of chronic kidney disease (CKD) and its negative effect on patient quality of life
• Explain limitations associated with current management of anemia of CKD
• Investigate safety and efficacy data of emerging investigational therapies for the management of anemia of CKD
• Identify patient-specific strategies that pharmacists may implement to facilitate the management of anemia of CKD

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-22-208-H01-P and 0290-0000-22-209-H01-T. The activity is available for CE credit through April 29, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Laura H. Waite, PharmD, BCPS, CLS, BC-ADM

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms